Mode
Home
Research
Clinical Trials Drug Pipeline Weekly Digests
Reference
Conditions Medications
Community
Questions
Text Size
Log in / Sign up
Home › Conditions › allergic asthma

Allergic asthma

1 published article · Updated continuously

Clinical Trial Landscape

Clinical Trials for allergic asthma

15 trials tracked for allergic asthma: 8 in phase 3 or 4.

15Trials tracked
8Phase 3 & 4
0Recruiting
0With published results
Phase distribution
Phase 4 5 Phase 3 3 Phase 2 3 Phase 1 1 Other / NA 3
  1. Phase 4 Predicting the Clinical Response to Omalizumab With Anti-Immunoglobulin E (IgE) Ab Response or Syk Expression in Basophils Completed
  2. Phase 4 A Description of Inflammatory Cell Types In Moderate to Severe Pediatric Asthma: Eosinophilic and Non Eosinophilic Sputum Markers While on Anti-IgE Therapy Completed
  3. Phase 4 A Study Evaluating the Persistency of Response With or Without Xolair (Omalizumab) After Long-term Therapy Completed
  4. Phase 4 Efficacy of Omalizumab in Adults (18-60 Years of Age) With Moderate-Severe, Persistent Allergic Asthma, Despite Receiving Inhaled Corticosteroids and Long Acting Beta-agonists Completed
  5. Phase 4 Study to Evaluate the Effect of Omalizumab on Improving the Tolerability of Specific Immunotherapy in Patients With Persistent Allergic Asthma Completed
  6. Phase 3 Characterization of the Role of Histamine in Children With Asthma Completed
Show 9 more trials
  1. Phase 3 Role of RhuMab-E25 in Reducing Exhaled Nitric Oxide (NO) in Allergic Asthma Completed
  2. Phase 3 Efficacy/ Safety of Omalizumab in Patients With Seasonal Allergic Asthma and Seasonal Allergic Rhinoconjunctivitis Completed
  3. Phase 2 The Tolerability and Effects of AZD8848 in Allergic Asthma Subjects Challenged With Inhaled Allergen Completed
  4. Phase 2 Effect of Gamma Tocopherol Enriched Supplementation on Response to Inhaled O3 Exposure Completed
  5. Phase 2 A Study of Omalizumab in the Prevention of Allergen Induced Airway Obstruction in Adults With Mild Allergic Asthma Completed
  6. Phase 1 A Phase 1, Randomized, Placebo-controlled, Dose-escalation Safety Study of MEDI4212 in Subjects With IgE >= 30 IU/mL Completed
  7. N/A Study on the Role of Treatment With Vitamin E on Asthmatic Responses in Allergic Asthmatics Completed
  8. N/A The Effect of Salmeterol on Eosinophil (EOS) Function Completed
  9. N/A Pharmacosurveillance Data Repository of Patients With and Without History of Anaphylactic Reactions Subsequent to Xolair Dosing Completed

Showing the 15 most-cited and recently-updated of 15 trials. Browse the full registry →

Trial data sourced from ClinicalTrials.gov. Counts describe the research landscape and are not a treatment recommendation. Informational only — not medical advice.

HCP Mode — summaries include clinical detail, trial data, and statistical outcomes.
Patient Mode — summaries use plain language, avoiding clinical jargon.
Astragali Radix metabolites show anti-inflammatory and immunomodulatory activities for allergic respiratory conditions
Drug Pipeline Sys. Review
Astragali Radix metabolites show anti-inflammatory and immunomodulatory activities for allergic respiratory conditions Astragali Radix metabolites show promise for allergic airway diseases
This narrative review examines the potential of Astragali Radix metabolites, including polysaccharides, saponins, and flavonoids, for allerg…
A review suggests Astragali Radix metabolites may help treat allergic asthma and related conditions through anti-inflammatory and immunomodu…
Frontiers Jun 3, 2026